Atea Pharmaceuticals (AVIR) Operating Margin (2021)
Historic Operating Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to 63.06%.
- Atea Pharmaceuticals' Operating Margin changed N/A to 63.06% in Q4 2021 from the same period last year, while for Sep 2022 it was 15.83%, marking a year-over-year decrease of 79400.0%. This contributed to the annual value of 39.38% for FY2021, which is 620600.0% up from last year.
- Latest data reveals that Atea Pharmaceuticals reported Operating Margin of 63.06% as of Q4 2021.
- Atea Pharmaceuticals' Operating Margin's 5-year high stood at 63.06% during Q4 2021, with a 5-year trough of 67.5% in Q3 2021.